| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |